BBHvsSPMD
VanEck Biotech ETF against SPDR Portfolio S&P 400 Mid Cap ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BBH | SPMD | |
|---|---|---|
| Expense ratio | 0.35% | 0.030% |
| Assets | $488M | $17.9B |
| Net flow, 1 month | +$3M | +$207M |
| Net flow, 1 year | −$23M | +$2.1B |
| Return, YTD | +26.1% | +10.0% |
| Return, 1 year | +38.7% | +11.0% |
| Avg daily volume | 12K | 1.5M |
| Holdings | 26 | 401 |
| Listed | Nov 23, 1999 | Nov 8, 2005 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS